OpenURL Connection Search

Select item for more details and to access through your institution.

Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia.
Published in:
American Journal of Hematology, 2023, v. 98, n. 12, p. E360, doi. 10.1002/ajh.27092
By:
- Patel, Parth C.;
- Ball, Somedeb;
- Jain, Akriti G.;
- Wang, Chen;
- Hussaini, Mohammad O.;
- Aguirre, Luis E.;
- Chan, Onyee;
- Yun, Seongseok;
- Kuykendall, Andrew;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Published in:
American Journal of Hematology, 2022, v. 97, n. 5, p. E185, doi. 10.1002/ajh.26504
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Aguirre, Luis E.;
- Al Ali, Najla;
- Zhang, Yumeng;
- Chan, Onyee;
- Kuykendall, Andrew T.;
- Sweet, Kendra L.;
- Lancet, Jeffrey E.;
- Swoboda, David M.;
- Padron, Eric;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
Article
Driver mutation‐specific clinical and genomic correlates differ between primary and secondary myelofibrosis.
Published in:
American Journal of Hematology, 2019, v. 94, n. 12, p. E314, doi. 10.1002/ajh.25625
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Sallman, David;
- Komrokji, Rami S.
Publication type:
Article
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients.
Published in:
American Journal of Hematology, 2019, v. 94, n. 1, p. 87, doi. 10.1002/ajh.25335
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.
Published in:
American Journal of Hematology, 2018, v. 93, n. 2, p. E49, doi. 10.1002/ajh.24980
By:
- Walter, Roland B.;
- Michaelis, Laura C.;
- Othus, Megan;
- Uy, Geoffrey L.;
- Radich, Jerald P.;
- Little, Richard F.;
- Hita, Sandi;
- Saini, Lalit;
- Foran, James M.;
- Gerds, Aaron T.;
- Klepin, Heidi D.;
- Hay, Annette E.;
- Assouline, Sarit;
- Lancet, Jeffrey E.;
- Couban, Stephen;
- Litzow, Mark R.;
- Stone, Richard M.;
- Erba, Harry P.
Publication type:
Article
Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: Analysis from a large, single institution experience.
Published in:
American Journal of Hematology, 2017, v. 92, n. 3, p. 232, doi. 10.1002/ajh.24627
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- Sweet, Kendra;
- Al Ali, Najla H.;
- Padron, Eric;
- Kubal, Timothy E.;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Autoimmune diseases and myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2016, v. 91, n. 5, p. E280, doi. 10.1002/ajh.24333
By:
- Komrokji, Rami S.;
- Kulasekararaj, Austin;
- Al Ali, Najla H.;
- Kordasti, Shahram;
- Bart-Smith, Emily;
- Craig, Benjamin M.;
- Padron, Eric;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Pinilla-Ibarz, Javier;
- List, Alan F.;
- Mufti, Ghulam J.;
- Epling-Burnette, Pearlie K.
Publication type:
Article
A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.
Published in:
American Journal of Hematology, 2015, v. 90, n. 9, p. 796, doi. 10.1002/ajh.24087
By:
- Griffin, Patrick T.;
- Komrokji, Rami S.;
- De Castro, Carlos M.;
- Rizzieri, David A.;
- Melchert, Magda;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptides.
Published in:
American Journal of Hematology, 2015, v. 90, n. 7, p. 602, doi. 10.1002/ajh.24014
By:
- Brayer, Jason;
- Lancet, Jeffrey E.;
- Powers, John;
- List, Alan;
- Balducci, Lodovico;
- Komrokji, Rami;
- Pinilla-Ibarz, Javier
Publication type:
Article
Phase II clinical study of erlotinib for treatment of myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2014, v. 89, n. 8, p. 809, doi. 10.1002/ajh.23749
By:
- Komrokji, Rami S.;
- Padron, Eric;
- Yu, Daohai;
- Fulp, William J.;
- Rodriguez, Yuraima;
- Tinsley, Sara;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2013, v. 88, n. 7, p. 566, doi. 10.1002/ajh.23454
By:
- Mishra, Asmita;
- Corrales-Yepez, Maria;
- Ali, Najla Al;
- Kharfan-Dabaja, Mohamed;
- Padron, Eric;
- Zhang, Ling;
- Epling-Burnette, Pearlie K.;
- Pinilla-Ibarz, Javier;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
Article
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes.
Published in:
American Journal of Hematology, 2012, v. 87, n. 11, p. 1006, doi. 10.1002/ajh.23303
By:
- Komrokji, Rami S.;
- Corrales-Yepez, Maria;
- Kharfan-Dabaja, Mohamed A.;
- Al Ali, Najla H.;
- Padron, Eric;
- Rollison, Dana E.;
- Pinilla-Ibarz, Javier;
- Zhang, Ling;
- Epling-Burnette, Pearlie K.;
- Lancet, Jeffrey E.;
- List, Alan F.
Publication type:
Article
Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia.
Published in:
BMC Cancer, 2004, v. 4, p. 56, doi. 10.1186/1471-2407-4-56
By:
- Raponi, Mitch;
- Belly, Robert T.;
- Karp, Judith E.;
- Lancet, Jeffrey E.;
- Atkins, David;
- Yixin Wang
Publication type:
Article
Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 400, doi. 10.1016/j.clml.2024.02.005
By:
- Ionescu, Filip;
- David, Jerel C.;
- Ravichandran, Apoorva;
- Sallman, David A.;
- Sweet, Kendra;
- Komrokji, Rami S.;
- Chan, Onyee;
- Kuykendall, Andrew;
- Padron, Eric;
- Faramand, Rawan;
- Bejanyan, Nelli;
- Khimani, Farhad;
- Elmariah, Hany;
- Pidala, Joseph;
- Mishra, Asmita;
- Perez, Lia;
- Nishihori, Taiga;
- Lancet, Jeffrey E.
Publication type:
Article
Utilization of Serial Next-Generation Sequencing Among Patients Receiving CPX-351 for Newly Diagnosed Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. e315, doi. 10.1016/j.clml.2023.07.002
By:
- Jain, Akriti G.;
- Ball, Somedeb;
- Aguirre, Luis E.;
- Tobon, Katherine A.;
- Chan, Onyee;
- Padron, Eric;
- Kuykendall, Andrew;
- Komrokji, Rami;
- Sallman, David;
- Lancet, Jeffrey E.;
- Sweet, Kendra
Publication type:
Article
MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01801-2
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S293, doi. 10.1016/S2152-2650(21)01700-6
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Al Ali, Najla;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Poster: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S227, doi. 10.1016/S2152-2650(21)01433-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Al Ali, Najla;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Poster: AML-225: Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S213, doi. 10.1016/S2152-2650(21)01340-9
By:
- Ball, Somedeb;
- Jain, Akriti G.;
- Ali, Najla Al;
- Hayden, Alexander;
- Swoboda, David M;
- Aguirre, Luis E.;
- Sallman, David A;
- Padron, Eric;
- Sweet, Kendra;
- Lancet, Jeffrey E;
- Watts, Justin;
- Pollyea, Daniel A;
- Komrokji, Rami S
Publication type:
Article
Oral Abstract: MDS-229: Assessment of Baseline Clinical and Molecular Characteristics in Indolent Chronic Myelomonocytic Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S201, doi. 10.1016/S2152-2650(21)01269-6
By:
- Aguirre, Luis E.;
- Ball, Somedeb;
- Ali, Najla Al;
- Sallman, David A.;
- Kuykendall, Andrew T.;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Komrokji, Rami
Publication type:
Article
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies.
Published in:
2021
By:
- Gesiotto, Quinto J.;
- Swoboda, David M.;
- Shallis, Rory M.;
- Al Ali, Najla;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Song, Jinming;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Zeidan, Amer M.;
- Komrokji, Rami S.;
- Sallman, David A.
Publication type:
letter
Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype.
Published in:
2021
By:
- Schwabkey, Zaker I.;
- Al Ali, Najla;
- Chan, Onyee;
- Sallman, David A.;
- Padron, Eric;
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
journal article
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities.
Published in:
2020
By:
- Sallman, David A.;
- Barnard, John;
- Al Ali, Najla H.;
- Garcia-Manero, Guillermo;
- Sekeres, Mikkael A.;
- DeZern, Amy;
- Steensma, David P.;
- Roboz, Gail;
- Jabbour, Elias;
- Maciejewski, Jaroslaw P.;
- Pierce, Sherry;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Kantarjian, Hagop;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
SF3B1 Mutations Negatively Predict for Response to Immunosuppressive Therapy in Myelodysplastic Syndromes.
Published in:
2020
By:
- Zhang, Qing;
- Haider, Mintallah;
- Al Ali, Najla H.;
- Lancet, Jeffrey E.;
- Epling-Burnette, Pearlie K.;
- List, Alan F.;
- Padron, Eric;
- Komrokji, Rami S.
Publication type:
journal article
Debate: Should All Older AML Patients and Younger Patients with Adverse Biology Routinely Receive HMA/of 3+7/? CON.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S89, doi. 10.1016/j.clml.2019.07.431
By:
- Lancet, Jeffrey E.
Publication type:
Article
Lenalidomide and Prednisone in Low and Intermediate-1 IPSS Risk, Non-Del(5q) Patients With Myelodysplastic Syndromes: Phase 2 Clinical Trial.
Published in:
2019
By:
- Komrokji, Rami S.;
- Al Ali, Najla H.;
- Padron, Eric;
- Cogle, Christopher;
- Tinsley, Sara;
- Sallman, David;
- Lancet, Jeffrey E.;
- Lis, Alan F.
Publication type:
journal article
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes.
Published in:
2019
By:
- Komrokji, Rami S.;
- Wei, Sheng;
- Mailloux, Adam W.;
- Zhang, Ling;
- Padron, Eric;
- Sallman, David;
- Lancet, Jeffrey E.;
- Tinsley, Sara;
- Nardelli, Lisa A.;
- Pinilla-Ibarz, Javier;
- Epling-Burnette, Pearlie K.;
- List, Alan F.
Publication type:
journal article
When Two Roads Diverge: Genetically Inspired Prognostic Scoring System (GIPSS) Outperforms DIPSS in Myelofibrosis Patients where the Two Risk Models Widely Differ.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S266, doi. 10.1016/j.clml.2018.07.183
By:
- Kuykendall, Andrew;
- Talati, Chetasi;
- Padron, Eric;
- Sweet, Kendra;
- Sallman, David;
- List, Alan F.;
- Lancet, Jeffrey E.;
- Komrokji, Rami
Publication type:
Article
Outcomes in Older Patients with Newly Diagnosed, High-risk/Secondary Acute Myeloid Leukemia (sAML) Who Received Consolidation in a Phase 3 Study of CPX-351 versus Conventional 7+3/5+2 Cytarabine and Daunorubicin.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S208, doi. 10.1016/j.clml.2018.07.064
By:
- Kolitz, Jonathan;
- Strickland, Stephen A.;
- Cortes, Jorge E.;
- Hogge, Donna;
- Lancet, Jeffrey E.;
- Goldberg, Stuart;
- Ryan, Robert J.;
- Chiarella, Michael;
- Louie, Arthur C.;
- Uy, Geoffrey L.
Publication type:
Article
A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia.
Published in:
2017
By:
- Mirza, Abu-Sayeef;
- Lancet, Jeffrey E.;
- Sweet, Kendra;
- Padron, Eric;
- Pinilla-Ibarz, Javier;
- Nardelli, Lisa;
- Cubitt, Christopher;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.
Published in:
2017
By:
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Al Ali, Najla;
- Sweet, Kendra;
- Padron, Eric;
- Sallman, David A.;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Zuckerman, Kenneth S.;
- Komrokji, Rami S.
Publication type:
journal article
Evidence for Selective Benefit of Sequential Treatment With Hypomethylating Agents in Patients With Myelodysplastic Syndrome.
Published in:
2017
By:
- Apuri, Susmitha;
- Al Ali, Najla;
- Padron, Eric;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Eltrombopag Use in Patients With Chronic Myelomonocytic Leukemia (CMML): A Cautionary Tale.
Published in:
2016
By:
- Ramadan, Hanadi;
- Duong, Vu H.;
- Al Ali, Najla;
- Padron, Eric;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- List, Alan F.;
- Komrokji, Rami S.
Publication type:
journal article
Poor outcome of patients with myelodysplastic syndrome after azacitidine treatment failure.
Published in:
2013
By:
- Duong, Vu H;
- Lin, Karen;
- Reljic, Tea;
- Kumar, Ambuj;
- Al Ali, Najla H;
- Lancet, Jeffrey E;
- List, Alan F;
- Komrokji, Rami S
Publication type:
Journal Article
A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution.
Published in:
Acta Haematologica, 2015, v. 133, n. 2, p. 249, doi. 10.1159/000365877
By:
- Peker, Deniz;
- Padron, Eric;
- Bennett, John M.;
- Zhang, Xiaohui;
- Horna, Pedro;
- Epling-Burnette, Pearlie K.;
- Lancet, Jeffrey E.;
- Pinilla-Ibarz, Javier;
- Moscinski, Lynn;
- List, alan F.;
- Komrokji, Rami S.;
- Zhang, Ling
Publication type:
Article
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome.
Published in:
Cancer (0008543X), 2012, v. 118, n. 10, p. 2659, doi. 10.1002/cncr.26567
By:
- Komrokji, Rami S.;
- Corrales-Yepez, Maria;
- Al Ali, Najla;
- Kharfan-Dabaja, Mohammad;
- Padron, Eric;
- Fields, Teresa;
- Lancet, Jeffrey E.;
- List, Alan F.
Publication type:
Article
Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome.
Published in:
Cancer (0008543X), 2011, v. 117, n. 7, p. 1463, doi. 10.1002/cncr.25598
By:
- Bello, Celeste;
- Daohai Yu;
- Komrokji, Rami S.;
- Weiwei Zhu;
- Wetzstein, Gene A.;
- List, Alan F.;
- Lancet, Jeffrey E.
Publication type:
Article
Integrative molecular subtypes of acute myeloid leukemia.
Published in:
Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00836-4
By:
- Mo, Qianxing;
- Yun, Seongseok;
- Sallman, David A.;
- Vincelette, Nicole D.;
- Peng, Guang;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Padron, Eric
Publication type:
Article
Integrative molecular subtypes of acute myeloid leukemia.
Published in:
2023
By:
- Mo, Qianxing;
- Yun, Seongseok;
- Sallman, David A.;
- Vincelette, Nicole D.;
- Peng, Guang;
- Zhang, Ling;
- Lancet, Jeffrey E.;
- Padron, Eric
Publication type:
Letter
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome.
Published in:
Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00744-z
By:
- Komrokji, Rami S.;
- Singh, Avani M.;
- Ali, Najla Al;
- Chan, Onyee;
- Padron, Eric;
- Sweet, Kendra;
- Kuykendall, Andrew;
- Lancet, Jeffrey E.;
- Sallman, David A.
Publication type:
Article
Farnesyl Transferase Inhibitors in Myeloid Disorders.
Published in:
Oncology (08909091), 2005, v. 19, n. 8, p. 1043
By:
- Lancet, Jeffrey E.
Publication type:
Article
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia.
Published in:
Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37174-6
By:
- Kuenzi, Brent M.;
- Remsing Rix, Lily L.;
- Kinose, Fumi;
- Kroeger, Jodi L.;
- Lancet, Jeffrey E.;
- Padron, Eric;
- Rix, Uwe
Publication type:
Article
Efficacy and safety of CPX-351 versus 7 + 3 chemotherapy by European LeukemiaNet 2017 risk subgroups in older adults with newly diagnosed, high-risk/secondary AML: post hoc analysis of a randomized, phase 3 trial.
Published in:
Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01361-w
By:
- Cortes, Jorge E.;
- Lin, Tara L.;
- Asubonteng, Kobby;
- Faderl, Stefan;
- Lancet, Jeffrey E.;
- Prebet, Thomas
Publication type:
Article
Phase II study of SU5416a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitorin patients with refractory myeloproliferative diseases.
Published in:
Cancer (0008543X), 2003, v. 97, n. 8, p. 1920
By:
- Francis J. Giles;
- Maureen A. Cooper;
- Lewis Silverman;
- Judith E. Karp;
- Jeffrey E. Lancet;
- Maurizio Zangari;
- Paul J. Shami;
- Khuda D. Khan;
- Alison L. Hannah;
- Julie M. Cherrington;
- Deborah A. Thomas;
- Guillermo Garcia-Manero;
- Maher Albitar;
- Hagop M. Kantarjian;
- Alison T. Stopeck
Publication type:
Article
Quality-adjusted Time Without Symptoms of disease or Toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML.
Published in:
Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01119-w
By:
- Cortes, Jorge E.;
- Lin, Tara L.;
- Uy, Geoffrey L.;
- Ryan, Robert J.;
- Faderl, Stefan;
- Lancet, Jeffrey E.
Publication type:
Article
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Published in:
Cancer (0008543X), 2022, v. 128, n. 21, p. 3880, doi. 10.1002/cncr.34459
By:
- Ball, Somedeb;
- Knepper, Todd C.;
- Deutsch, Yehuda E.;
- Samra, Wassim;
- Watts, Justin M.;
- Bradley, Terrence J.;
- Chan, Onyee;
- Hussaini, Mohammad Omar;
- Zhang, Ling;
- Sweet, Kendra L.;
- Kuykendall, Andrew T.;
- Talati, Chetasi;
- Padron, Eric;
- Komrokji, Rami S.;
- Lancet, Jeffrey E.;
- Sallman, David A.
Publication type:
Article
Disease-related thrombocytopenia in myelofibrosis is defined by distinct genetic etiologies and is associated with unique prognostic correlates.
Published in:
2022
By:
- Kuykendall, Andrew T.;
- Mo, Qianxing;
- Sallman, David A.;
- Ali, Najla Al;
- Chan, Onyee;
- Yun, Seongseok;
- Sweet, Kendra L.;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
journal article
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy‐related myelodysplastic syndromes.
Published in:
British Journal of Haematology, 2022, v. 198, n. 4, p. 713, doi. 10.1111/bjh.18319
By:
- Volpe, Virginia O.;
- Al Ali, Najla;
- Chan, Onyee;
- Padron, Eric;
- Sallman, David A.;
- Kuykendall, Andrew;
- Sweet, Kendra;
- Lancet, Jeffrey E.;
- Komrokji, Rami S.
Publication type:
Article
Association of EZH2 protein expression by immunohistochemistry in myelodysplasia related neoplasms with mutation status, cytogenetics and clinical outcomes.
Published in:
British Journal of Haematology, 2019, v. 184, n. 3, p. 450, doi. 10.1111/bjh.15099
By:
- McGraw, Kathy L.;
- Nguyen, Johnny;
- Al Ali, Najla H.;
- Komrokji, Rami S.;
- Sallman, David;
- Zhang, Xiaohui;
- Song, Jinming;
- Padron, Eric;
- Lancet, Jeffrey E.;
- Moscinski, Lynn C.;
- List, Alan F.;
- Zhang, Ling
Publication type:
Article
Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis.
Published in:
British Journal of Haematology, 2013, v. 163, n. 3, p. 315, doi. 10.1111/bjh.12528
By:
- Kharfan‐Dabaja, Mohamed A.;
- Hamadani, Mehdi;
- Reljic, Tea;
- Pyngolil, Rachel;
- Komrokji, Rami S.;
- Lancet, Jeffrey E.;
- Fernandez, Hugo F.;
- Djulbegovic, Benjamin;
- Kumar, Ambuj
Publication type:
Article

Found: 63